Literature DB >> 23303991

The microbiota of the human genitourinary tract: trying to see the forest through the trees.

David H Martin1, Marcela Zozaya, Rebecca Lillis, Julia Miller, Michael J Ferris.   

Abstract

Based on traditional microbiological methods, namely cultivation and microscopic analyses, the vaginal microbiota (VMB) has been defined as healthy when it is predominated by hydrogen peroxide-producing Lactobacillus spp., most prominently Lactobacillis crispatus. Similarly, the VMB has been defined as bacterial vaginosis (BV) when it is predominated by Gardnerella vaginalis as well as a number of other anaerobic bacterial species. BV is associated with a distinct vaginal discharge syndrome, poor pregnancy outcomes, pelvic inflammatory disease, post-operative wound infections, and endometritis after elective abortions. Additionally, BV predisposes women to infection by HIV as well as other sexually transmitted diseases (STDs). The application of molecular techniques over the last decade to studies of the VMB has significantly advanced our understanding of its structure and variation. It is now clear that the diversity of the VMB is far more complex than previously recognized; it is comprised of many heretofore unknown bacteria in addition to those previously identified by culture. Here we describe the application of 454 pyrosequencing technology to a study of vaginal specimens from 92 women attending the New Orleans STD clinic in an effort to obtain a more precise view of how different types of "trees" (bacteria) assemble to form a recognizable "forest" (VMB). This knowledge will be useful in the design of future clinical studies that investigate the mechanisms by which the vaginal microbiome influences human health and disease.

Entities:  

Mesh:

Year:  2012        PMID: 23303991      PMCID: PMC3540603     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  47 in total

1.  An international study of the interobserver variation between interpretations of vaginal smear criteria of bacterial vaginosis.

Authors:  U Forsum; T Jakobsson; P G Larsson; H Schmidt; A Beverly; A Bjørnerem; B Carlsson; P Csango; G Donders; P Hay; C Ison; F Keane; H McDonald; H Moi; J-J Platz-Christensen; J Schwebke
Journal:  APMIS       Date:  2002-11       Impact factor: 3.205

2.  Evaluation of the bacterial vaginal flora of 20 postmenopausal women by direct (Nugent score) and molecular (polymerase chain reaction and denaturing gradient gel electrophoresis) techniques.

Authors:  Jeremy P Burton; Gregor Reid
Journal:  J Infect Dis       Date:  2002-11-22       Impact factor: 5.226

3.  Vaginal microbiome of reproductive-age women.

Authors:  Jacques Ravel; Pawel Gajer; Zaid Abdo; G Maria Schneider; Sara S K Koenig; Stacey L McCulle; Shara Karlebach; Reshma Gorle; Jennifer Russell; Carol O Tacket; Rebecca M Brotman; Catherine C Davis; Kevin Ault; Ligia Peralta; Larry J Forney
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-03       Impact factor: 11.205

4.  Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.

Authors:  J C Carey; M A Klebanoff; J C Hauth; S L Hillier; E A Thom; J M Ernest; R P Heine; R P Nugent; M L Fischer; K J Leveno; R Wapner; M Varner
Journal:  N Engl J Med       Date:  2000-02-24       Impact factor: 91.245

5.  Bacterial vaginosis in early pregnancy may predispose for preterm birth and postpartum endometritis.

Authors:  Bo Jacobsson; Peter Pernevi; Lene Chidekel; Jens Jörgen Platz-Christensen
Journal:  Acta Obstet Gynecol Scand       Date:  2002-11       Impact factor: 3.636

6.  Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease.

Authors:  Harold C Wiesenfeld; Sharon L Hillier; Marijane A Krohn; Antonio J Amortegui; R Phillips Heine; Daniel V Landers; Richard L Sweet
Journal:  Obstet Gynecol       Date:  2002-09       Impact factor: 7.661

7.  Detection of Atopobium vaginae in postmenopausal women by cultivation-independent methods warrants further investigation.

Authors:  Jeremy P Burton; Estelle Devillard; Peter A Cadieux; Jo-Anne Hammond; Gregor Reid
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis.

Authors:  Harald Leitich; Barbara Bodner-Adler; Mathias Brunbauer; Alexandra Kaider; Christian Egarter; Peter Husslein
Journal:  Am J Obstet Gynecol       Date:  2003-07       Impact factor: 8.661

9.  Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis.

Authors:  Rita Verhelst; Hans Verstraelen; Geert Claeys; Gerda Verschraegen; Joris Delanghe; Leen Van Simaey; Catharine De Ganck; Marleen Temmerman; Mario Vaneechoutte
Journal:  BMC Microbiol       Date:  2004-04-21       Impact factor: 3.605

10.  Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis.

Authors:  Michael J Ferris; Alicia Masztal; Kenneth E Aldridge; J Dennis Fortenberry; Paul L Fidel; David H Martin
Journal:  BMC Infect Dis       Date:  2004-02-13       Impact factor: 3.090

View more
  17 in total

1.  The Vaginal Microbiome: Current Understanding and Future Directions.

Authors:  David H Martin; Jeanne M Marrazzo
Journal:  J Infect Dis       Date:  2016-08-15       Impact factor: 5.226

2.  Comparison of different hypervariable regions of 16S rRNA for taxonomic profiling of vaginal microbiota using next-generation sequencing.

Authors:  Auttawit Sirichoat; Nipaporn Sankuntaw; Chulapan Engchanil; Pranom Buppasiri; Kiatichai Faksri; Wises Namwat; Wasun Chantratita; Viraphong Lulitanond
Journal:  Arch Microbiol       Date:  2020-11-22       Impact factor: 2.552

3.  Biogenic Amines Increase the Odds of Bacterial Vaginosis and Affect the Growth of and Lactic Acid Production by Vaginal Lactobacillus spp.

Authors:  Joanna-Lynn C Borgogna; Michelle D Shardell; Savannah G Grace; Elisa K Santori; Benjamin Americus; Zhong Li; Alexander Ulanov; Larry Forney; Tiffanie M Nelson; Rebecca M Brotman; Jacques Ravel; Carl J Yeoman
Journal:  Appl Environ Microbiol       Date:  2021-04-27       Impact factor: 4.792

4.  Rapid and Profound Shifts in the Vaginal Microbiota Following Antibiotic Treatment for Bacterial Vaginosis.

Authors:  Bryan T Mayer; Sujatha Srinivasan; Tina L Fiedler; Jeanne M Marrazzo; David N Fredricks; Joshua T Schiffer
Journal:  J Infect Dis       Date:  2015-02-12       Impact factor: 5.226

5.  Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection.

Authors:  David H Martin; Marcela Zozaya; Rebecca A Lillis; Leann Myers; M Jacques Nsuami; Michael J Ferris
Journal:  J Infect Dis       Date:  2013-03-12       Impact factor: 5.226

6.  Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women.

Authors:  Hanneke Borgdorff; Evgeni Tsivtsivadze; Rita Verhelst; Massimo Marzorati; Suzanne Jurriaans; Gilles F Ndayisaba; Frank H Schuren; Janneke H H M van de Wijgert
Journal:  ISME J       Date:  2014-03-06       Impact factor: 10.302

7.  Oral microbiome development during childhood: an ecological succession influenced by postnatal factors and associated with tooth decay.

Authors:  Majda Dzidic; Maria C Collado; Thomas Abrahamsson; Alejandro Artacho; Malin Stensson; Maria C Jenmalm; Alex Mira
Journal:  ISME J       Date:  2018-06-13       Impact factor: 10.302

8.  In Silico and Experimental Evaluation of Primer Sets for Species-Level Resolution of the Vaginal Microbiota Using 16S Ribosomal RNA Gene Sequencing.

Authors:  William J Van Der Pol; Ranjit Kumar; Casey D Morrow; Eugene E Blanchard; Christopher M Taylor; David H Martin; Elliot J Lefkowitz; Christina A Muzny
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

9.  Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence.

Authors:  Lívia Custódio Pereira; Amabel Fernandes Correia; Zita Dinis Lopes da Silva; Ceres Nunes de Resende; Fabiana Brandão; Rosane Mansan Almeida; Yanna Karla de Medeiros Nóbrega
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-03-13       Impact factor: 3.267

10.  Mining for viral fragments in methylation enriched sequencing data.

Authors:  Klaas Mensaert; Wim Van Criekinge; Olivier Thas; Ed Schuuring; Renske D M Steenbergen; G Bea A Wisman; Tim De Meyer
Journal:  Front Genet       Date:  2015-02-04       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.